amiodarone has been researched along with Esophageal Reflux in 1 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chantepie, A | 1 |
Lefort, B | 1 |
Méot, M | 1 |
Jandali, JC | 1 |
Soulé, N | 1 |
Chantreuil, J | 1 |
Vaillant, MC | 1 |
Tisseron, B | 1 |
1 other study available for amiodarone and Esophageal Reflux
Article | Year |
---|---|
[Failure of amiodarone in supraventricular tachycardia in an infant: drug interaction with Gaviscon(®)?].
Topics: Alginates; Aluminum Hydroxide; Amiodarone; Antacids; Anti-Arrhythmia Agents; Drug Combinations; Drug | 2014 |